Results 101 to 110 of about 7,602 (197)

Intrafamilial Disease Heterogeneity in Primary Hyperoxaluria Type 1

Kidney International Reports
Introduction: Primary hyperoxaluria type 1 (PH1) is known for its variable clinical course, even within families. However, the extent of this heterogeneity has not been well-studied.
Lisa J. Deesker, Hazal A. Karacoban, Elisabeth L. Metry, Sander F. Garrelfs, Justine Bacchetta, Olivia Boyer, Laure Collard, Arnaud Devresse, Wesley Hayes, Sally-Anne Hulton, Cristina Martin-Higueras, Shabbir H. Moochhala, Thomas J. Neuhaus, Jun Oh, Larisa Prikhodina, Przemyslaw Sikora, Michiel J.S. Oosterveld, Jaap W. Groothoff, Giorgia Mandrile, Bodo B. Beck   +19 more
doaj   +1 more source

Metabolic alterations in non-alcoholic fatty liver disease (NAFLD): consequences of AGXT downregulation on glyoxylate detoxification [PDF]

Non-alcoholic fatty liver disease (NAFLD) encompasses a wide range of liver diseases, where excessive hepatic lipid accumulation is a common factor. It is highly prevalent worldwide, and is associated with an elevated risk of developing more severe liver
Gianmoena, Kathrin
core   +1 more source

Primary hyperoxaluria [PDF]

Biochemical Journal, 1971
openaire   +4 more sources

Microscopic Haematuria [PDF]

, 2005
A 30 year old man is referred for a medical check up before taking a life insurance policy. He is asymptomatic, gives no relevant history, is on no treatment and physical examination is unremarkable. Routine dip-stick analysis of a mid­stream specimen of
Vella, Mario P.
core  

Genetic Diagnosis of Hyperoxaluria Type 3 Patients Using Haplotype Analysis

Kidney & Blood Pressure Research
Introduction: An autosomal recessive hereditary disorder of the glyoxylate metabolism, primary hyperoxaluria (PH), causes an excess of oxalate to be formed in the body.
Sadegh Tavakoli Ataabadi, Leila Behi, Marzieh Mojbafan, Nakysa Hooman   +3 more
doaj   +1 more source

Efficacy of oral citrate administration in primary hyperoxaluria [PDF]

, 2017
Urinary citrate is a potent inhibitor of calcium oxalate (CaOx) crystallization, but oral citrate has rarely been used in patients with primary hyperoxaluria (PH).
Blau, N., Hoppe, B., Leumann, E., Neuhaus, T.   +3 more
core  

Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function [PDF]

, 2018
Tamm-Horsfall protein (THP) powerfully inhibits calcium oxalate crystal aggregation, but structurally abnormal THPs from recurrent calcium stone formers may promote crystal aggregation.
Hess, Bernhard, Jaggi, Markus, Nakagawa, Yasushi, Zipperle, Ljerka   +3 more
core  

Variability in urinary oxalate measurements between six international laboratories [PDF]

, 2017
Background. Hyperoxaluria is a major risk factor for kidney stone formation. Although urinary oxalate measurement is part of all basic stone risk assessment, there is no standardized method for this measurement. Methods.
Adams Huet, Beverley, Asplin, John R., Bonny, Olivier, Frey, Felix J., Hesse, Albrecht, Holmes, Ross P., Knight, John, Lieske, John C., Maalouf, Naim M., Nuoffer, Jean-Marc, Pasch, Andreas, Siener, Roswitha, Zerwekh, Joseph E.   +12 more
core  

My Kidneys Just Stopped Working: Adult Onset End-Stage Renal Disease From Rare Metabolic Disorder [PDF]

, 2011
Oertel, Mark J, Yarlagadda, Sri
core   +2 more sources

Primary Hyperoxaluria

Annals of the Academy of Medicine, Singapore, 2010
Niranjan, Khandelwal, Kushaljit Singh, Sodhi, Vivek, Virmani, Navneet, Sharma   +3 more
openaire   +2 more sources